Overview
Paola Pierucci practices in Darlinghurst, Australia. Ms. Pierucci is rated as an Experienced expert by MediFind in the treatment of Pompe Disease. Her top areas of expertise are Obesity Hypoventilation Syndrome (OHS), Cramp-Fasciculation Syndrome, Primary Lateral Sclerosis, Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease), and Lung Transplant.
Her clinical research consists of co-authoring 53 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, she has co-authored 2 articles in the study of Pompe Disease.
Locations
Darlinghurst, NSW, Australia
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Cramp-Fasciculation SyndromeMs. Pierucci isAdvanced. Learn about Cramp-Fasciculation Syndrome.
- Obesity Hypoventilation Syndrome (OHS)
- Primary Lateral SclerosisMs. Pierucci isAdvanced. Learn about Primary Lateral Sclerosis.
- Experienced
- Acute Respiratory Distress Syndrome (ARDS)Ms. Pierucci isExperienced. Learn about Acute Respiratory Distress Syndrome (ARDS).
- Amyotrophic Lateral Sclerosis (ALS or Lou Gehrig's Disease)
- Becker Muscular DystrophyMs. Pierucci isExperienced. Learn about Becker Muscular Dystrophy.
- Central Sleep ApneaMs. Pierucci isExperienced. Learn about Central Sleep Apnea.
- Chronic Obstructive Pulmonary Disease (COPD)
- COVID-19Ms. Pierucci isExperienced. Learn about COVID-19.